Don't miss our upcoming webinars! Subscribe today!
In this webinar:
In May-June, 2020, the Canadian Cancer Survivor Network (CCSN) commissioned Leger to conduct a national survey to evaluate the impact that COVID-19 has had on cancer patients, survivors, pre-diagnosis patients, and caregivers. The results of our first survey revealed that the pandemic response has triggered another public health crisis - the postponement and cancellation of essential cancer tests, procedures, and treatments.
CCSN commissioned Leger for a second survey in December, 2020 to evaluate the impact that the suspension of cancer services during the first wave is currently having on those who have been affected by cancer.
Join CCSN and Leger as we present the results of the COVID-19 and Cancer Care Disruption in Canada Survey - Wave 2 and hear from members of the cancer community about how the pandemic has directly impacted them.
View the YouTube video: https://youtu.be/qN4Hq7OtBys
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don't miss our upcoming webinars. Subscribe today!
Presented by: Marjut Huotari - Vice President, Healthcare Insights at Leger
In this webinar:
The Canadian Cancer Survivor Network commissioned Leger, a Canadian-owned polling and market research firm, to discover how the disruption of cancer care has affected Canadian cancer patients, survivors, and caregivers. This third survey Leger conducted for CCSN took place from June 10 to July 4, 2021.
Join CCSN and Leger as we present the results of the survey on COVID-19 and Cancer Care Disruption in Canada - Wave 3, and hear from members of the cancer community about how the pandemic has directly impacted them.
Watch the YouTube video: https://www.youtube.com/watch?v=CTomgU3AUSQ
To learn more about CCSN, visit us at survivornet.ca
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don't miss our upcoming webinars! Subscribe today!
In this webinar, Dr. Durand will review the changing landscape of HPV-related diseases and cancers. She will discuss methods of HPV prevention for current cancer patients and cancer survivors. Attendees will learn about the evidence for HPV vaccination in adults. Practical tips will be provided on how to access HPV vaccination.
View the YouTube video: https://youtu.be/wFgpmqOpzC4
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don't miss our upcoming webinars. Subscribe today!
This presentation will highlight the promising new therapeutic strategies in the treatment of gliomas, with a focus on trials or therapies that will soon be available for Canadian patients.
View the YouTube video: https://youtu.be/ibbEuvSF7xY
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
During March, CCSN and patient advocates met with Alberta MLAs to discuss our COVID-19 and Care Care Disruption - Wave 2 Survey and the importance of prioritizing cancer patients in the vaccine rollout. In this webinar, we will hear from Tim Monds, a lung cancer patient advocate, share some outcomes from our meetings, discuss the key findings from our survey, and take a closer look at the Alberta data.
View the YouTube video: https://youtu.be/Tq5OJqA5_Rc
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don't miss our upcoming webinars! Subscribe today!
Presented by: Dr. Paul C Rogers, MBChB, FRCPC, FRCP(Lond), MBA
In this webinar, Dr. Rogers will discuss:
1) Nutrition from a cancer control perspective
2) The importance of continuous longitudinal nutritional assessment from diagnosis through survivorship
3) The role of nutrition on the well being of cancer survivors and chronic disease prevention
4) Incorporating nutritional research in survivorship research
View the YouTube video: https://youtu.be/Wk3dJ0rvJUY
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don’t miss our upcoming webinars: Subscribe today!
In this webinar:
Join CCSN and Marjut Huotari, VP-Healthcare Insights at Leger, as we present the results of the COVID-19 and Cancer Care Disruption in Canada Survey and hear from members of the cancer community about how the pandemic has directly impacted them.
View the video:
https://youtu.be/6ub1ot806-A
To learn more about CCSN, visit us at survivornet.ca
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don't miss our upcoming webinars! Subscribe today!
Presented by: Dr. Poul Sorensen, MD, PhD, FRCPC; Dr. Muhammad Zulfiqar, MD; Ted Taylor, Patient Advocate
In this webinar, we will hear from Dr. Sorensen about his groundbreaking discovery and how it contributed to the development of tumour agnostic treatments. Dr. Zulfiqar, a medical oncologist at the BC Cancer Agency, will further discuss TRK fusion cancers and how he has been able to treat patients. Lastly, we will hear from Ted Taylor, a TRK fusion cancer patient diagnosed with glioblastoma (GBM) multiform being treated with Vitrakvi.
Watch the YouTube video: https://youtu.be/RAkItUeZ23Q
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don't miss our upcoming webinars: Subscribe today!
In this webinar:
Dr. Paula Gordon will share information on when individuals should start screening for breast cancer, and how often to screen - in order for cancer to be found as early as possible, and to allow the least aggressive options for treatment. Dr. Gordon will also discuss how to screen for recurrence in women who’ve had cancer, explain why these methods are not always offered, and suggest what you can do to improve access to optimal screening.
View the video: https://youtu.be/7uFksz6_4Zk
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don't miss our upcoming webinars. Subscribe today!
Presented by: Marjut Huotari - Vice President, Healthcare Insights at Leger
In this webinar:
The Canadian Cancer Survivor Network commissioned Leger, a Canadian-owned polling and market research firm, to discover how the disruption of cancer care has affected Canadian cancer patients, survivors, and caregivers. This third survey Leger conducted for CCSN took place from June 10 to July 4, 2021.
Join CCSN and Leger as we present the results of the survey on COVID-19 and Cancer Care Disruption in Canada - Wave 3, and hear from members of the cancer community about how the pandemic has directly impacted them.
Watch the YouTube video: https://www.youtube.com/watch?v=CTomgU3AUSQ
To learn more about CCSN, visit us at survivornet.ca
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don't miss our upcoming webinars! Subscribe today!
In this webinar, Dr. Durand will review the changing landscape of HPV-related diseases and cancers. She will discuss methods of HPV prevention for current cancer patients and cancer survivors. Attendees will learn about the evidence for HPV vaccination in adults. Practical tips will be provided on how to access HPV vaccination.
View the YouTube video: https://youtu.be/wFgpmqOpzC4
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don't miss our upcoming webinars. Subscribe today!
This presentation will highlight the promising new therapeutic strategies in the treatment of gliomas, with a focus on trials or therapies that will soon be available for Canadian patients.
View the YouTube video: https://youtu.be/ibbEuvSF7xY
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
During March, CCSN and patient advocates met with Alberta MLAs to discuss our COVID-19 and Care Care Disruption - Wave 2 Survey and the importance of prioritizing cancer patients in the vaccine rollout. In this webinar, we will hear from Tim Monds, a lung cancer patient advocate, share some outcomes from our meetings, discuss the key findings from our survey, and take a closer look at the Alberta data.
View the YouTube video: https://youtu.be/Tq5OJqA5_Rc
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don't miss our upcoming webinars! Subscribe today!
Presented by: Dr. Paul C Rogers, MBChB, FRCPC, FRCP(Lond), MBA
In this webinar, Dr. Rogers will discuss:
1) Nutrition from a cancer control perspective
2) The importance of continuous longitudinal nutritional assessment from diagnosis through survivorship
3) The role of nutrition on the well being of cancer survivors and chronic disease prevention
4) Incorporating nutritional research in survivorship research
View the YouTube video: https://youtu.be/Wk3dJ0rvJUY
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don’t miss our upcoming webinars: Subscribe today!
In this webinar:
Join CCSN and Marjut Huotari, VP-Healthcare Insights at Leger, as we present the results of the COVID-19 and Cancer Care Disruption in Canada Survey and hear from members of the cancer community about how the pandemic has directly impacted them.
View the video:
https://youtu.be/6ub1ot806-A
To learn more about CCSN, visit us at survivornet.ca
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don't miss our upcoming webinars! Subscribe today!
Presented by: Dr. Poul Sorensen, MD, PhD, FRCPC; Dr. Muhammad Zulfiqar, MD; Ted Taylor, Patient Advocate
In this webinar, we will hear from Dr. Sorensen about his groundbreaking discovery and how it contributed to the development of tumour agnostic treatments. Dr. Zulfiqar, a medical oncologist at the BC Cancer Agency, will further discuss TRK fusion cancers and how he has been able to treat patients. Lastly, we will hear from Ted Taylor, a TRK fusion cancer patient diagnosed with glioblastoma (GBM) multiform being treated with Vitrakvi.
Watch the YouTube video: https://youtu.be/RAkItUeZ23Q
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don't miss our upcoming webinars: Subscribe today!
In this webinar:
Dr. Paula Gordon will share information on when individuals should start screening for breast cancer, and how often to screen - in order for cancer to be found as early as possible, and to allow the least aggressive options for treatment. Dr. Gordon will also discuss how to screen for recurrence in women who’ve had cancer, explain why these methods are not always offered, and suggest what you can do to improve access to optimal screening.
View the video: https://youtu.be/7uFksz6_4Zk
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don’t miss our upcoming webinars: Subscribe today!
In this webinar:
Our presenter, Filomena Servidio, will be reviewing the results of CCSN’s National Prostate Cancer Survey based on the recently released Prostate Cancer Survey Report. Join us as we learn more about the prostate cancer journey, and the need to better inform and support prostate cancer patients and their caregivers in Canada.
View the video:
https://youtu.be/RHwIsZx6x4A
To learn more about CCSN, visit us at survivornet.ca
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don’t miss our upcoming webinars: Subscribe today!
The CanRehab Team brings together a large group of patients, researchers, and clinicians at four Canadian centres and includes three concurrent projects focused on improving access to effective, appropriate, and timely cancer rehabilitation (CanRehab Team).
The objectives of the presentation are: 1) to provide a background on cancer rehabilitation; 2) to introduce the CanRehab Team projects; and 3) to provide an overview of the team structure including a call for interest to the Patient Advisory Committee.
View the YouTube video: https://youtu.be/B2tcIsrw4WE
To learn more about CCSN, visit us at survivornet.ca
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don't miss our upcoming webinars: Subscribe today!
In this webinar:
Dr. Krista Noonan is a medical oncologist specializing in thoracic and genitourinary malignancies at BC Cancer, Surrey Centre. Her research interests focus on thoracic and genitourinary malignancies and health services research. On Thursday, February 27, join Dr. Noonan as she: - Reviews the advancements in systemic therapy in lung cancer over the past decade - Highlights how the advancements in systemic therapy have dramatically improved quality of life and length of life.
View the video: https://youtu.be/3DaUwQ8ab44
To learn more about CCSN, visit us at survivornet.ca
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don't miss our upcoming webinars. Subscribe today!
In this webinar:
Attendees will learn about the role of exercise in the cancer care pathway, and the potential benefits from building a habit of moving more. We will also discuss the EXCEL study: EXercise for Cancer to Enhance Living Well, and how it is providing a sustainable exercise and behaviour change program to those living with cancer in rural and remote regions across Canada. Learn what is involved in this exercise research program and how to get involved online now!
View the YouTube video: https://youtu.be/BIOviCzESwA
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
EAOCRC Summit Framing the Conversation: Strategic Challenges in Current Medical Care that Contribute to Young Adult Colorectal Cancer (CRC) Incidence and Mortality. Session I - The Dimensions of the EAOCRC Problem.
5th Annual Early Age Onset Colorectal Cancer Summit - Session II: Family History Ascertainment in the US - What Steps are Needed to Improve the Well Documented Less Than Optimal Status of this Situation?
As part of the 4th Annual Early Age Onset CRC Summit theNational Colorectal Cancer Roundtable (NCCRT) Family History and Early Onset Task Group hosted a Special Symposium focused on the importance of Family Health History for colorectal cancer, including advanced adenomas, and its importance in preventing colorectal cancer. The Symposium included presentations on the current challenges and opportunities surrounding ascertainment and documentation of actionable family health history information in primary care.
5th Annual Early Age Onset Colorectal Cancer Summit - Session III: Earliest Possible Diagnosis and Treatment Through Timely Recognition of Symptoms and Signs of Young Adult CRC
Tonight’s speakers: Dr. Dan Sargent and Kim Ryan
Disclaimer: “This Report is not an official event of the 2012 Gastrointestinal Cancers Symposium. Not sponsored or endorsed by any of the cosponsoring organizations of the 2012 Gastrointestinal Cancers Symposium.”
On September 3, 2015, Ovarian cancer survivors and FDA Patient Representatives Peg Ford, Susan Leighton and Annie Ellis were invited to provide the patient perspective at the recent Ovarian Cancer Endpoints Workshop hosted by the Food and Drug Administration (FDA). This meeting was co-sponsored by the Society of Gynecologic Oncology (SGO), the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO). Many important topics to the ovarian cancer community were discussed, including novel clinical trial designs, biomarkers, and new classes of agents such as immunotherapies.
Date held: February 12, 2015
Presented by: Deb Davison, Genomic Health
Topics discussed:
The latest in genomic testing and its role in cancer treatment
The most recent results from Genomic Health’s second independent clinical validation study of Oncotype DX® in DCIS patients
Q&A session about the implications of this research
Take a deeper dive into the topic of Precision Medicine and what this means for colorectal cancer. This webinar is brought to you by Fight CRC’s Research Advocacy Training and Support (RATS) program.
Don’t miss our upcoming webinars. Subscribe today!
About this webinar:
In this webinar, presented by Marjut Huotari, Vice President of Healthcare Insights at Leger, you will learn about cancer patient and caregiver concerns as society opens. How do cancer patients feel? What risks are they willing to take?
About the presenter:
Marjut Huotari has a Bachelor and a Master of Business Administration from the Schulich School of Business, York University. She is a marketing professional with over 20 years of experience working with the pharmaceutical industry, including 14 years working in the pharmaceutical industry on the client side. With Leger, Marjut manages both qualitative and quantitative market research, conducting research with a variety of healthcare practitioners and patients. With her team, she aims to help her clients to understand the issues and help develop solutions.
View the Video: https://bit.ly/youtubeCancerCantWaitCCSNFourthLegersurveyonCOVID19andcancercare
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don't miss our upcoming webinars! Subscribe today!
In April, CCSN virtually met with MPPs throughout Ontario to discuss our COVID-19 and Cancer Care - Wave 2 Survey. During these meetings, we discussed the difficulty cancer patients and pre-diagnosis patients have had with accessing cancer services during the pandemic and the importance of ensuring the cancer patients receive their 1st and 2nd vaccine doses in a timely manner.
In this webinar, CCSN's Public Policy Analyst Conrad will begin by sharing some of the highlights from our meetings with Ontario MPPs. He will then turn things over to our patient advocates and they will share some of their reflections from our meetings as well as their own experiences with accessing cancer care during the pandemic. Lastly, Conrad will take a closer look at the Ontario data from our survey.
View the YouTube video: https://youtu.be/05u4i89WFfQ
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
How general internists can participate in the continuum of care for patients with cancer. (Talk given at Internal Medicine Grand Rounds, St. Elizabeth Hospital, General Santos City, 10 Feb 2021.)
Don’t miss our upcoming webinars: Subscribe today!
In this webinar:
Our presenter, Filomena Servidio, will be reviewing the results of CCSN’s National Prostate Cancer Survey based on the recently released Prostate Cancer Survey Report. Join us as we learn more about the prostate cancer journey, and the need to better inform and support prostate cancer patients and their caregivers in Canada.
View the video:
https://youtu.be/RHwIsZx6x4A
To learn more about CCSN, visit us at survivornet.ca
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don’t miss our upcoming webinars: Subscribe today!
The CanRehab Team brings together a large group of patients, researchers, and clinicians at four Canadian centres and includes three concurrent projects focused on improving access to effective, appropriate, and timely cancer rehabilitation (CanRehab Team).
The objectives of the presentation are: 1) to provide a background on cancer rehabilitation; 2) to introduce the CanRehab Team projects; and 3) to provide an overview of the team structure including a call for interest to the Patient Advisory Committee.
View the YouTube video: https://youtu.be/B2tcIsrw4WE
To learn more about CCSN, visit us at survivornet.ca
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don't miss our upcoming webinars: Subscribe today!
In this webinar:
Dr. Krista Noonan is a medical oncologist specializing in thoracic and genitourinary malignancies at BC Cancer, Surrey Centre. Her research interests focus on thoracic and genitourinary malignancies and health services research. On Thursday, February 27, join Dr. Noonan as she: - Reviews the advancements in systemic therapy in lung cancer over the past decade - Highlights how the advancements in systemic therapy have dramatically improved quality of life and length of life.
View the video: https://youtu.be/3DaUwQ8ab44
To learn more about CCSN, visit us at survivornet.ca
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don't miss our upcoming webinars. Subscribe today!
In this webinar:
Attendees will learn about the role of exercise in the cancer care pathway, and the potential benefits from building a habit of moving more. We will also discuss the EXCEL study: EXercise for Cancer to Enhance Living Well, and how it is providing a sustainable exercise and behaviour change program to those living with cancer in rural and remote regions across Canada. Learn what is involved in this exercise research program and how to get involved online now!
View the YouTube video: https://youtu.be/BIOviCzESwA
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
EAOCRC Summit Framing the Conversation: Strategic Challenges in Current Medical Care that Contribute to Young Adult Colorectal Cancer (CRC) Incidence and Mortality. Session I - The Dimensions of the EAOCRC Problem.
5th Annual Early Age Onset Colorectal Cancer Summit - Session II: Family History Ascertainment in the US - What Steps are Needed to Improve the Well Documented Less Than Optimal Status of this Situation?
As part of the 4th Annual Early Age Onset CRC Summit theNational Colorectal Cancer Roundtable (NCCRT) Family History and Early Onset Task Group hosted a Special Symposium focused on the importance of Family Health History for colorectal cancer, including advanced adenomas, and its importance in preventing colorectal cancer. The Symposium included presentations on the current challenges and opportunities surrounding ascertainment and documentation of actionable family health history information in primary care.
5th Annual Early Age Onset Colorectal Cancer Summit - Session III: Earliest Possible Diagnosis and Treatment Through Timely Recognition of Symptoms and Signs of Young Adult CRC
Tonight’s speakers: Dr. Dan Sargent and Kim Ryan
Disclaimer: “This Report is not an official event of the 2012 Gastrointestinal Cancers Symposium. Not sponsored or endorsed by any of the cosponsoring organizations of the 2012 Gastrointestinal Cancers Symposium.”
On September 3, 2015, Ovarian cancer survivors and FDA Patient Representatives Peg Ford, Susan Leighton and Annie Ellis were invited to provide the patient perspective at the recent Ovarian Cancer Endpoints Workshop hosted by the Food and Drug Administration (FDA). This meeting was co-sponsored by the Society of Gynecologic Oncology (SGO), the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO). Many important topics to the ovarian cancer community were discussed, including novel clinical trial designs, biomarkers, and new classes of agents such as immunotherapies.
Date held: February 12, 2015
Presented by: Deb Davison, Genomic Health
Topics discussed:
The latest in genomic testing and its role in cancer treatment
The most recent results from Genomic Health’s second independent clinical validation study of Oncotype DX® in DCIS patients
Q&A session about the implications of this research
Take a deeper dive into the topic of Precision Medicine and what this means for colorectal cancer. This webinar is brought to you by Fight CRC’s Research Advocacy Training and Support (RATS) program.
Don’t miss our upcoming webinars. Subscribe today!
About this webinar:
In this webinar, presented by Marjut Huotari, Vice President of Healthcare Insights at Leger, you will learn about cancer patient and caregiver concerns as society opens. How do cancer patients feel? What risks are they willing to take?
About the presenter:
Marjut Huotari has a Bachelor and a Master of Business Administration from the Schulich School of Business, York University. She is a marketing professional with over 20 years of experience working with the pharmaceutical industry, including 14 years working in the pharmaceutical industry on the client side. With Leger, Marjut manages both qualitative and quantitative market research, conducting research with a variety of healthcare practitioners and patients. With her team, she aims to help her clients to understand the issues and help develop solutions.
View the Video: https://bit.ly/youtubeCancerCantWaitCCSNFourthLegersurveyonCOVID19andcancercare
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don't miss our upcoming webinars! Subscribe today!
In April, CCSN virtually met with MPPs throughout Ontario to discuss our COVID-19 and Cancer Care - Wave 2 Survey. During these meetings, we discussed the difficulty cancer patients and pre-diagnosis patients have had with accessing cancer services during the pandemic and the importance of ensuring the cancer patients receive their 1st and 2nd vaccine doses in a timely manner.
In this webinar, CCSN's Public Policy Analyst Conrad will begin by sharing some of the highlights from our meetings with Ontario MPPs. He will then turn things over to our patient advocates and they will share some of their reflections from our meetings as well as their own experiences with accessing cancer care during the pandemic. Lastly, Conrad will take a closer look at the Ontario data from our survey.
View the YouTube video: https://youtu.be/05u4i89WFfQ
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
How general internists can participate in the continuum of care for patients with cancer. (Talk given at Internal Medicine Grand Rounds, St. Elizabeth Hospital, General Santos City, 10 Feb 2021.)
YCN Breast Educational Meeting 2015-NICE Breast Cancer Quality Standards- E A...Jay Naik
Background to the the NICE Breast Cancer Quality Standards, desinged as simple measures to ensure delivery of quality care. Regional audit data for 3 Trusts presented comparing and contrasting performance against selected audit data.
Современное лечение ВИЧ: новые парадигмы в АРТ / Contemporary Management of H...hivlifeinfo
Набор слайдов c рассмотрением важных вопросов об АРТ первого ряда, арв-препаратами пролонгированного действия и схемами АРТ с двумя препаратами, акцент в публикации на роль новых стратегий.
For more information contact: Slideshare@marcusevans.com
Presentation delivered by Donna Medina, Regional Director,OSF Hospice and Homecare Foundation at the marcus evans Home Care Leadership Summit held on July 13 & 14 2015 in Palm Beach FL.
Современное лечение ВИЧ: новые подходы к оптимизации АРТ/Contemporary Managem...hivlifeinfo
Вопросы, связанные с АРТ первого ряда, смена арв-стратегии для пациентов с вирусной супрессией, акцентом на возрастающую роль новыхантиретровирусных стратегий.
Secondary Cancers, Health Behaviour and Cancer Screening Adherence in survivo...Cancer Institute NSW
Over 50% of patients undergoing allogeneic BMT can now be expected to become long-term survivors. Unfortunately many survivors experience an increased risk of secondary cancers, infections and chronic diseases.
Comparative Effectiveness of a Multifaceted Intervention to Improve Adherence to Annual Colorectal Cancer Screening in Community Health Centers (RCT)
Présentation de David W. Baker au colloque "Recherche interventionnelle contre le cancer : Réunir chercheurs, décideurs et acteurs de terrain » - 17 et 18 novembre 2014, BnF, Paris
About the Webinar: Michelle Colero, Executive Director of Bladder Cancer Canada, will cover the essentials of bladder cancer facts and symptoms while also outlining the support and educational resources provided by Bladder Cancer Canada for those dealing with a diagnosis. Additionally, she’ll share ways individuals can contribute to raising awareness and supporting our community.
About the Webinar: Alcohol is classified as a Group one carcinogen and is estimated to be one of the top three causes of cancer deaths worldwide. Yet, over 40 per cent of people in Canada remain unaware that alcohol consumption increases the risk of developing at least nine cancers. In this presentation, we’ll look at what is and isn’t known about the relationship between alcohol and cancer. We’ll explore what the Canadian Cancer Society is doing to raise awareness of alcohol as a modifiable cancer risk factor, its commitment to funding world-leading research on this subject, and its advocacy for stronger policies that reduce, and increase awareness about the risk of cancer related to, alcohol consumption. Attendees will be invited to seek more information and/or take action on this important topic. We hope you’ll join us in learning more about cancer risk and alcohol — the most commonly used psychoactive substance in Canada.
Dr. Rob Rutledge returns for his first webinar of 2024 to discuss the basics behind emotional intelligence. Learn how to develop greater emotional awareness, and learn how to settle fear and frustration. Dr. Rutledge will also share tips on how to live in a more peaceful and connected way as you navigate through your cancer journey.
About the Webinar: Health technology assessment (HTA), the approval process for drugs and healthcare technology, the processes and organizations that support them, such as Canadian Agency for Drugs and Technologies in Health (CADTH), have evolved over the years in response to changing healthcare system priorities and the need to establish their legitimacy. Don Husereau will provide an overview of current processes in Canada, and highlight their perceived (and real) shortcomings and what can be done to overcome these. He will highlight that some perceived weaknesses (such as review times) are not as bad as they appear while perceived strengths (such as stakeholder involvement) need considerable improvement. He will also discuss other opportunities for HTA to innovate and whether there are current plans to address these.
About this Webinar: The time between regulatory approval for new drugs and when drugs became publicly available to patients averaged 736 days (25 months) in 2022. This is double the average time reported in comparable Organisation for Economic Development (OECD) countries. This webinar will highlight variations in drug listing time for new drugs across time, provinces, and type of drugs (oncology vs. non-oncology). It will also present the specific phases involved in moving a drug from approval stage to listing, and the time spent in each. This Conference Board of Canada analysis uses IQVIA’s Market Access Metrics Database (2012 to 2023), which tracks all new products and their indications through the Canadian access journey.
About the Webinar: Learn about pancreatic cancer symptoms, diagnosis, treatment options, statistics, supports and barriers. The presentation will also include some helpful tools that can improve quality of life for those with pancreatic cancer, including the Craig's Cause's PERT (Pancreatic Enzyme Replacement Therapy) calculator and available patient support programs.
As referenced by John Adams in his 2024 CCSN Webinar on the US importing drugs from Canada, this is a slide deck from Health Canada which outlines the timetable and actions taken by the government on this particular issue.
About this Webinar: John Adams takes a dive behind the headlines, news stories and media releases to better understand any real threats to Canadian patients getting the prescription drugs they need.
About this Webinar: We know that methods of eating and diet are a large part of cancer care, but how can you make your diet work for you in your cancer journey? Dr. Rob Rutelege is back to present the latest science around healthy eating and cancer care. In addition, Dr. Rutledge will share the benefits of time-restricted eating, and how you can incorporate it into your daily routine.
Colorectal cancer is the second leading cause of cancer death in Canada, with approximately 24,100 Canadians diagnosed with the disease in 2023. The incidence of colorectal cancer has been declining in Canadians over 50 years of age, largely due to population-based screening programs. Recent evidence has shown, however, that rates have been increasing in adults younger than 50 years. Given that younger adults are typically classified as at low risk for colorectal cancer, this epidemiologic shift is cause for concern.
Individuals under the age of 50 now represent a significant number of colorectal cancer cases. The disease is often being diagnosed at a later stage, and tumour characteristics tend to be more lethal. As for what is accounting for the increasing trend, ongoing research efforts focus on environmental toxicities, lifestyle patterns, and the gut microbiome.
In this webinar, we will present an overview of the current evidence surrounding the rising rates of colorectal cancer in young adults and discuss the unique needs of this patient population, through screening, diagnosis, treatment, and survivorship. A young colorectal cancer patient will share his lived experience in managing this disease and the impact that cancer has had on himself and his family.
About this Talk: This talk will provide a nutritional perspective on the role of diet in cancer focusing on healthy fats known as omega-3 fatty acids. Sources, amounts and types of omega-3 fatty acids will be highlighted. Clinical and experimental evidence in support of a role for omega-3 fatty acids in the prevention and treatment of breast cancer will be presented. Lastly, some practical strategies to support a healthy diet will be shared.
About the Webinar: Genomic testing has already become commonplace in oncology, but exponential growth in more comprehensive genomic tests, other innovative tests and testing approaches in oncology, as well as a number of other therapeutic areas is expected in the coming years. With the emergence of more complex, more expensive, and more promising tests, policymakers and healthcare providers may be challenged to provide these to patients at the pace of innovation. Don Husereau will describe what conditions are necessary for equitable access to advanced innovative testing, how major Canadian provinces are doing, and what more needs to be done in the coming years to benefit all patients.
About this Webinar: This talk will explore breast screening for women 40-49. The benefits and harms for screening will be discussed, as well as what is unique about breast cancer in women in their 40s. In order to understand the controversy around current guidelines recommending against screening women 40-49, we will review the evidence upon which these guidelines are based, and their impact on breast cancer outcomes for these women.
About this Webinar: This presentation will discuss the pathway to pharmaceutical treatments in Canada that involve health technology assessment reviews and decision making. Observations on the current challenges and the importance of patient input to inform decision making will also be discussed. Finally, the key elements that can be critical to successful outcomes will be presented.
About this Webinar: When Canadians turn on the tap for a drink of water or a shower, we take for granted that the water is safe. Few are aware that old asbestos cement water pipes still deliver water to millions of people. As these pipes age and deteriorate, asbestos erodes into the water and poses health concerns, including cancer.
Dr. Meg Sears, Chair of the Board of Prevent Cancer Now, and board member Julian Branch will talk about the history of asbestos in water, the science behind ingested asbestos, and recent developments.
André Deschamps will show the results of the Europa UOMO Euproms studies. These are the first studies ever from patients for patients, measuring the burden of treatment. More than 5000 patients have shared with us their experiences after treatment. The data has been analyzed by the university of Rotterdam in the Netherlands and has been published in peer reviewed scientific papers.
This webinar will serve as an introduction to Cancer and Work, a website that “was designed to address the unique needs of cancer survivors with returning, remaining, changing work or looking for work after a diagnosis of cancer. The website provides newly created information, resources, and interactive tools for cancer survivors, healthcare providers, employers, and highlights helpful information from across the globe.” The talk will include 10 steps to return to work, and job search ideas for cancer survivors
This webinar will have two perspectives.
Jasveen will be presenting about the impact of cancer and treatment on a person’s physical, cognitive & mental health and how an Occupational therapist can work with the person to gradually overcome these challenges to return to work with or without modifications. The presentation will cover some case studies of past success with the opportunity to answer questions at the end.
Then we will hear from Jen who has experienced her own journey with breast cancer and how she advocated for herself and occupational therapy to help her return to full time employment.
About this Webinar: we’ll summarize the findings of a 10-minute online study conducted by Leger among cancer patients who experienced Long-COVID. We identified 119 cancer patients, diagnosed within the past 10 years, who developed symptoms or were diagnosed with Long-COVID. We primarily wanted to understand how Long-COVID impacted cancer patients and their ability to receive treatment. We also asked about the effect on their overall wellbeing, their ability to access Long-COVID treatments and assistance, and the ongoing impact to this day.
About this Presenter: Colette Faust is a Research Director at Leger (largest Canadian-owned market research company) and has 10 years of market research experience, spending the last 3 years in the healthcare industry. As a member of Leger’s North American Healthcare team, Colette has worked on both quantitative and qualitative healthcare research among healthcare professionals, patients, and the general population across a variety of topics including oncology. Colette received her B.A. in Psychology and Media & Communications from Muhlenberg College in Allentown, PA.
Various cancer treatments can impact one’s gut health and digestive system. This presentation will discuss why a healthy gut is important to overall health. We will talk about the roles the gut is involved in beyond just digestion. We will also discuss nutrition strategies that will support our gut health and promote a healthy microbiome.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Cancer Still Waiting: Impact of COVID-19 Crisis on Cancer Patients and their Ability to Receive Treatment - Wave 2
1. IMPACT OF COVID-19 CRISIS ON
CANCER PATIENTS AND THEIR
ABILITY TO RECEIVE TREATMENT
– WAVE 2
Thursday February 4, 2021
1:00 pm
Presented by Marjut Huotari,
VP – Healthcare Insights, Leger
416-262-4200
1
2. Research context and objectives
Research methodology
• Recruitment
• Research methodology
Key findings
Conclusion
Q&A
1
2
3
4
5
OVERVIEW
2
3. RESEARCH CONTEXT AND OBJECTIVES
Leger, on behalf of the Canadian Cancer Survivor Network (CCSN), conducted a second wave of the study to assess
the extent to which the disruption of cancer care caused by COVID-19 impacts cancer patients and caregivers, from
an emotional and physical wellness perspective.
• Have appointments been cancelled or rescheduled?
• for treatment, surgery, etc.
• Have there been delays in diagnosis?
• are patients waiting for tests, e.g. biopsies, ultrasounds, etc. to confirm a diagnosis?
• Have there been changes in treatment?
• IV to oral therapy, in-hospital to in-home, etc.
• Have patients avoided going to the ER?
• for symptoms related to their cancer diagnosis etc.
• What is the emotional and mental impact of diagnosis and treatment delays?
• How are patients and caregivers interacting with the doctor managing their cancer
• virtual consults, in person visits, etc.
• How do they rate the quality of care during COVID-19
• Has clinical trial participation been affected or put on hold?
Key topics addressed
in the survey
3
4. RESEARCH METHODOLOGY – SAMPLE SIZE
Data collection took place from December 3rd to
December 29th, 2020.
First wave with a total sample of 1,243 data
collection took place from May 22nd to June 10th,
2020.
Web survey of 1,638 Canadians, including
1,198 Canadians diagnosed with cancer,
248 Caregivers and 192 Canadians in the
pre-diagnosis stage.
The survey was made available in both
English and French.
REGIONAL ACHIEVEMENTS
QUE 30%
ON 30%
AB 10%
BC 12% SK 4%
ATL 8%
MB 6%
4
5. RESEARCH METHODOLOGY – RECRUITMENT
SCREENING CRITERIA:
• 18 years or older and currently living in Canada
• Respondents qualified as:
A patient, if they were diagnosed with cancer
A caregiver, if a currently living family member / someone they
care for was diagnosed with cancer
Pre-diagnosis, if they are in the process of trying to determine
if they have cancer, or to rule out cancer
• A maximum of 35% of patients to be in remission
RECRUITMENT:
• All respondents were recruited via our LEO PANEL – Leger’s proprietary consumer panel
with nearly 500,000 members (largest in Canada)
5
7. KEY STUDY FINDINGS
Restrictions put in place to manage the COVID-19 crisis continue to have considerable
DISRUPTION to many aspects of cancer care in Canada.
Despite consulting doctors using virtual modes of interaction, DELAYS in APPOINTMENTS
and TREATMENT has had a MAJOR IMPACT on patients and their caregivers.
Among those who had in-person appointments and scheduled procedures/surgeries
cancelled or postponed, it took on average 34 DAYS to RESCHEDULE THE APPOINTMENT and
on average 52 DAYS to RESCHEDULE THE PROCEDURE/SURGERY.
The many DISRUPTIONS to cancer care have taken a MENTAL AND EMOTIONAL TOLL.
CONCERNS about receiving adequate cancer care BOTH DURING and AFTER COVID-19 fuel
anxieties. Anxiety levels are now back to what it was DURING the HEIGHT of the FIRST WAVE
of the pandemic.
1
2
4
5
3
8
8. Even split by gender Tend to skew older: 66 YEARS (59) on average
Regionally representative across Canada
QUE 29%
ON 31%
AB 11%
BC 12%
SK 3% ATL 8%
MB 6%
RESPONDENT PROFILE – PATIENTS
BREAST (23%) and PROSTATE (20%) cancer
account for about half.
Other cancers among ~1 in 10 patients include
colon / rectal, melanoma, skin, lung, and bladder.
23% 20%
Stage 1
23%
Stage 2
11%
Stage 3
8%
Stage 4 /
Metastatic
8%
Remission
38%
1 in 10 say they are unsure of their stage of cancer.
<2 YEARS
29%
2-5 YEARS
46%
6-10 YEARS
12%
>10 YEARS
13%
TIME SINCE
DIAGNOSIS
varies greatly
among patients;
a MAJORITY
(two-thirds) were
diagnosed in the
PAST 5 YEARS.
48%
51%
RURAL: 27% (24%)
TOWN/CITY: 50% (51%)
URBAN/METRO: 22% (25%)
Good mix of locations by population
(52%) (48%)
(20%) (16%) (10%) (10%) (35%)
(30%)
(35%)
(19%)
(16%)
(28%) (20%)
(#) represents W1 data
9
9. RESPONDENT PROFILE – CAREGIVERS
Good mix of all ages: 47 YEARS (47) on average
Regionally representative across Canada
QUE 27%
ON 26%
AB 8%
BC 12%
SK 8% ATL 10%
MB 9%
<2 YEARS
59%
2-5 YEARS
35%
6-10 YEARS
4%
>10 YEARS
2%
TIME SINCE
DIAGNOSIS
varies but skews
towards more
recently diagnosed;
6-in-10 were
diagnosed within
the last 2 years
36%
63%
RURAL: 22% (19%)
TOWN/CITY: 55% (56%)
URBAN/METRO: 21% (24%)
Good mix of locations by population
RELATIONSHIP TO THE CANCER PATIENT
Spouse / partner
– 21%
Daughter (in-law)
– 14%
Mother (in-law) –
15%
Father (in-law) –
8%
Skews towards females
1 in 10 say they are unsure of their stage of cancer.
(60%) (40%)
Most common cancer types of
person being cared for
PROSTATE
CANCER: 14%
COLON / RECTAL
CANCER: 12%
BREAST
CANCER: 40%
LUNG
CANCER: 17%
(50%)
(27%)
(11%)
(13%)
(10%) (23%) (16%) (16%) (23%)
(23%) (19%) (10%) (9%)
(#) represents W1 data
10
10. RESPONDENT PROFILE – PRE-DIAGNOSIS
Skews younger with 65% under 55 years
48 YEARS (46) on average
Majority from QC, followed by ON
QUE 38%
ON 31%
AB 10%
BC 9%
SK 3% ATL 7%
MB 2%
60%
40%
RURAL: 20% (14%)
TOWN/CITY: 47% (51%)
URBAN/METRO: 33% (33%)
Tend to skew towards city / metro
Skews towards males
As they wait for a
possible cancer
diagnosis…
(34%) (46%)
(#) represents W1 data
11
11. PATIENTS CAREGIVERS PRE-DIAGNOSIS
JUST OVER HALF continue to have their APPOINTMENTS CANCELLED, POSTPONED or RESCHEDULED,
more so patients in the metastatic stage
51%
7%
9%
14%
6%
70%
28%
27%
38%
28%
61%
39%
26%
RECENTLY DIAGNOSED – 11%
METASTATIC STAGE – 18%
ADJUVANT STAGE – 12%
55% (vs. 54% in W1) HAVE HAD APPOINTMENTS
CANCELLED, POSTPONED OR RESCHEDULED
14% (vs. 16% in W1) AVOIDED VISITING AN ER
13% (vs. 15% in W1) HAVE HAD SURGERIES /
PROCEDURES CANCELLED
10% HAVE AVOIDED VISITING A HOSPITAL FOR
CANCER CARE*
N/A
EXPERIENCE WITH APPOINTMENTS DURING COVID-19
(50%) (66%) (74%)
(12%) (23%) (30%)
RECENTLY DIAGNOSED – 62%
METASTATIC STAGE – 75%
ADJUVANT STAGE – 37%
NOTE:
RECENTLY DIAGNOSED = DIAGNOSED <2 YEARS AGO
ADJUVANT STAGE = STAGE 1/2/3 CANCER
METASTATIC STAGE = STAGE 4 CANCER
*Attribute added this wave – no trending available
(#) represents W1 data
N/A
18% HAVE HAD LAB / DIAGNOSTIC TESTS
CANCELLED OR RESCHEDULED*
(12%) (26%) (40%)
12
12. PATIENTS CAREGIVERS
CLINICAL TRIALS WERE
ALSO IMPACTED
Enrollment in clinical trials have slightly gone down with 5% (vs. 11% last wave) reporting
being enrolled in or being considered for a clinical trial
Two-in-ten (18%) patients, who were enrolled in or in the process of being enrolled in a clinical
trial report the clinical trial being put on hold or stopped altogether
Close to four-in-ten (36%) recently diagnosed patients report a clinical trial being put
on hold or stopped altogether
NOTE:
RECENTLY DIAGNOSED = DIAGNOSED <2 YEARS AGO
ADJUVANT STAGE = STAGE 1/2/3 CANCER
METASTATIC STAGE = STAGE 4 CANCER
8%
6%
4%
37%
31%
24%
13% HAVE HAD A CHANGE MADE TO TREATMENT
/ MODE OF ADMINISTRATION OF TREATMENT*
7% (vs. 11% in W1) EXPERIENCED DELAYS IN
STARTING / CONTINUING TREATMENT
10% HAVE BEEN RECEIVING TREATMENT AT HOME
INSTEAD OF A HEALTHCARE FACILITY*
EXPERIENCE WITH TREATMENT DURING COVID-19
RECENTLY DIAGNOSED – 15%
METASTATIC STAGE – 22%
(8%) (23%)
ADJUVANT STAGE – 33%
*Attribute added this wave – no trending available
(#) represents W1 data
Slight DECREASE in PATIENTS EXPERIENCING DELAYS IN STARTING / CONTINUING TREATMENT. However,
22% METASTATIC stage patients and 37% CAREGIVERS report CHANGE in their TREATMENT PROTOCOL.
13
13. PATIENTS CAREGIVERS PRE-DIAGNOSIS
AVERAGE TIME TAKEN TO RESCHEDULE APPOINTMENT
AMONG THOSE WHO HAD
IN-PERSON APPOINTMENTS
CANCELLED/ POSTPONED/
RESCHEDULED, IT TOOK ON
AVERAGE 34 DAYS TO
RESCHEDULE THE
APPOINTMENT
HOWEVER, 36% SAY NO
RESCHEDULED
APPOINTMENT TIME YET
38
days
36% said no
rescheduled
appointment
time yet
(n=592)
27
days
33% said no
rescheduled
appointment
time yet
(n=170)
27
days
40% said no
rescheduled
appointment
time yet
(n=104)
PATIENTS CAREGIVERS PRE-DIAGNOSIS
AVERAGE TIME TAKEN TO RESCHEDULE PROCEDURE/SURGERY
AMONG THOSE WHO HAD A
SCHEDULED PROCEDURE OR
SURGERY CANCELLED OR
POSTPONED, IT TOOK ON
AVERAGE 52 DAYS TO
RESCHEDULE IT
HOWEVER, 46% SAY NO
RESCHEDULED
APPOINTMENT TIME YET
61
days
39% said no
rescheduled
appointment
time yet
(n=105)
44
days
45% said no
rescheduled
appointment
time yet
(n=66)
41
days
61% said no
rescheduled
appointment
time yet
(n=49)
Of those who had in-person appointments and scheduled procedures/surgeries cancelled or postponed,
OVER A THIRD (36%) claim that they are YET TO HAVE APPOINTMENTS RESCHEDULED and NEARLY HALF
(46%) are YET TO HAVE PROCEDURES/SURGERIES RESCHEDULED
14
14. DELAYS IN APPOINTMENTS AND
TREATMENT CONTINUE TO HAVE
A HUGE IMPACT ON ALL WITH
72% (vs. 74% in W1) REPORTING
IT HAVING AN IMPACT ON THEIR
HEALTH
PATIENTS
69%
CAREGIVERS
83%
PRE-DIAGNOSIS
71%
Anxious
Stressed
Worried / concerned
IT CONTINUES TO HAVE A
MAJOR IMPACT ON MENTAL
AND EMOTIONAL HEALTH WITH
MANY HIGHLIGHTING BEING:
PATIENTS CAREGIVERS PRE-DIAGNOSIS
MAIN REASONS FOR AVOIDING BOOKING AN APPOINTMENT WITH A DOCTOR (UNAIDED)
42%
15%
8%
COVID-19 concerns / Too many
COVID-19 cases
They are not taking appointments /
hard to get a hold of
Too anxious / afraid / stressed / sick
51%
6%
5%
39%
9%
7%
13% OF THOSE SURVEYED SAID
THEY AVOIDED BOOKING AN
APPOINTMENT WITH A DOCTOR
FOR THEIR CANCER EVEN IF
THEY NEEDED ONE, MAINLY
BECAUSE OF FEAR OF COVID-19
AND TOO MANY COVID-19
CASES
(n=91) (n=63) (n=56)
IMPACT OF HAVING APPOINTMENTS POSTPONED / TREATMENTS DELAYED (UNAIDED)
(n=446) (n=154) (n=105)
(68%) (89%) (82%)
(#) represents W1 data
“I don’t want to be in contact with too many
people to avoid getting the COVID-19. It’s
stupid going and receiving same answers.”
“Outbreak of COVID at
the hospital.”
“COVID 19 is a higher priority and
my doctor has put me on hold.”
“Daily stress... actually minute by
minute stress as it just never goes
away. Plus, its seriously affecting
my spouse.”
“Added stress, anxiety and worry.
Empathy for their pain and suffering.
Also makes it hard to plan your own life.
Always just kind of on standby.”
“Stress for me and my loved ones.
Created tension with my spouse
leading to arguments.”
COVID-19 CONCERN is the MAIN BARRIER for avoiding booking an appointment with a doctor.
Appointments being cancelled and postponed continues to affect all with 72% of those who experienced
DELAYS reporting a MAJOR IMPACT on their MENTAL and EMOTIONAL health.
15
15. 63% (vs. 56% in W1) ARE CONCERNED ABOUT THEIR ABILITY
TO RECEIVE HOSPITAL CARE IF NEEDED
63% (vs. 56% in W1) ARE CONCERNED ABOUT THEIR ABILITY
TO BE CARED FOR IN ER IF NEEDED
62% (vs. 51% in W1) ARE CONCERNED ABOUT BEING ABLE
TO RECEIVE CANCER TREATMENT IN TIMELY FASHION
59% ARE CONCERNED ABOUT RECEIVING IN-PERSON CARE*
59% (vs. 54% in W1) ARE CONCERNED BEING ABLE TO GET
TESTS RELATED TO CANCER
56% (vs. 54% in W1) ARE CONCERNED ABOUT BEING ABLE TO
GET HELP FOR SIDE EFFECTS RELATED TO TREATMENT OR
NEW SYMPTOMS
55% (vs. 54% in W1) ARE CONCERNED ABOUT BEING ABLE
TO SEE DOCTOR MANAGING CANCER FOR FOLLOW-UPS
PATIENTS CAREGIVERS PRE-DIAGNOSIS
59%
58%
55%
54%
52%
51%
50%
77%
77%
80%
74%
77%
74%
74%
71%
71%
73%
66%
67%
63%
N/A
*VERY + SOMEWHAT CONCERNED
MAIN CONCERNS* ABOUT EACH OF THE FOLLOWING DURING COVID-19
(51%)
(51%)
(46%) (67%) (59%)
METASTATIC STAGE – 72%
ADJUVANT STAGE – 62%
RECENTLY DIAGNOSED – 55%
RECENTLY DIAGNOSED – 66%
NOTE: RECENTLY DIAGNOSED = DIAGNOSED <2 YEARS AGO, ADJUVANT STAGE = STAGE 1/2/3 CANCER & METASTATIC STAGE = STAGE 4 CANCER (#) represents W1 data
PATIENTS are SIGNIFICANTLY MORE CONCERNED about RECEIVING CARE in HOSPITAL / ER if needed and
receiving CANCER TREATMENT in a timely manner compared to after the first wave of COVID-19
16
*Attribute added this wave – no trending available
16. AFTER SHOWING DOWNWARD TREND, ANXIETY LEVELS
AMONG CANCER PATIENTS, CAREGIVERS AS WELL AS
THOSE IN PRE-DIAGNOSIS ARE BACK TO WHAT THEY
WERE DURING THE HEIGHT OF FIRST WAVE
Five-in-ten (50%) patients report currently being very or
somewhat anxious; the most anxious being:
Those with metastatic cancer (64%)
Those recently diagnosed (63%)
Those diagnosed with lung cancer (63%)
Female patients (54%)
Three-quarters (74%) of caregivers said they were
anxious.
Nearly three-quarters (73%) of those pre-diagnosed
with cancer say they feel very or somewhat anxious
during this second wave of COVID-19
This number rises to slightly over eight-in-ten
(83%) among females pre-diagnosed with cancer
26%
49%
34%
50%
63%
79%
63%
74%
49%
73%
58%
73%
Patients Caregivers Pre-diagnosis
PRIOR to COVID-19
being declared a
pandemic and
restrictions put in place
DURING the HEIGHT
OF FIRST WAVE of
the COVID-19
pandemic, when self-
isolation restrictions
were in place
When RESTRICTIONS
began to RELAX and
EASE after the first
wave*
DURING the SECOND
WAVE of the COVID-19
pandemic, when
restrictions are being
imposed again in many
places*
NOTE: RECENTLY DIAGNOSED = DIAGNOSED <2 YEARS AGO & METASTATIC STAGE = STAGE 4 CANCER
(35%)
(64%)
(65%)
(49%)
(71%)
(76%)
(#) represents W1 data
With appointments being cancelled / postponed and concerns around receiving hospital / ER care and
timely treatment, ANXIETY LEVELS are BACK to what they were DURING the HEIGHT of the FIRST WAVE of
the pandemic
17
17. PATIENTS CAREGIVERS PRE-DIAGNOSIS
HEALTHCARE PROVIDERS INTERACTED WITH DURING COVID-19
64%
51%
32%
28%
Specialists
Family doctor/ GP
Pharmacists
Allied healthcare professionals
77%
79%
61%
65%
40%
84%
41%
29%
(45%)
(39%)
(56%)
(60%)
(51%)
(47%)
AMONG THOSE WHO
INTERACTED WITH EACH
PHYSICIAN DURING COVID-19
MODES OF INTERACTION
DURING THE PANDEMIC
78%
57%
65%
56%
GPs
Specialists
Virtual
(telephone, video consult,
e-mail, instant messaging,
text / SMS)
In-person
SATISFACTION
(VERY/SOMEWHAT
SATISFIED)
91%
91%
94%
97%
77%
56%
62%
61%
GPs
Specialists
SATISFACTION
(VERY/SOMEWHAT
SATISFIED)
80%
82%
91%
92%
70%
61%
66%
47%
GPs
Specialists
SATISFACTION
(VERY/SOMEWHAT
SATISFIED)
77%
87%
84%
78%
Significant increase in in-
person interactions this
wave.
Among all virtual modes of
interactions, telephone
consult was used the most
(31%)
(85%)
(35%)
(81%)
(39%)
(72%)
Patients and caregivers report
significant increase interactions
with physicians, Specialists and
GPs, this wave
Recently diagnosed patients are
more likely to say they interacted
with GPs (63%) and specialists
(83%) this wave
Metastatic stage patients (85%)
report increased interactions with
Specialists this wave
(76%)
(34%)
(80%)
(31%)
(72%)
(40%)
(#) represents W1 data
Compared to last wave, PATIENTS and CAREGIVERS report SIGNIFICANT INCREASES in INTERACTIONS with
PHYSICIANS, especially IN-PERSON interactions. However, majority continue to have virtual (more so
telephone) interactions over in-person consultation.
18
18. PATIENTS CAREGIVERS PRE-DIAGNOSIS
SATISFACTION WITH QUALITY OF CANCER CARE RECEIVED DURING COVID-19
18%
6%
15%
61%
Very satisfied
Somewhat satisfied
Somewhat unsatisfied /
not at all satisfied
Don’t know
10%
22%
29%
39% Very satisfied
Somewhat satisfied
Somewhat unsatisfied /
not at all satisfied
Don’t know
8%
26%
35%
31% Very satisfied
Somewhat satisfied
Somewhat unsatisfied /
not at all satisfied
Don’t know
MAIN REASONS FOR BEING SOMEWHAT SATISFIED / SOMEWHAT UNSATISFIED / NOT AT ALL SATISFIED:
Delays in getting care
Doctor not available / appointments cancelled
Status of appointments / treatment unknown
Having to deal with doctor over the phone
PATIENTS CAREGIVERS PRE-DIAGNOSIS
TOP CONCERNS ABOUT RECEIVING CARE DURING COVID-19 (UNAIDED)
51%
23%
8%
8%
7%
Access to health care (treatment, HCPs, tests, etc.)
Fear of getting COVID-19
Having appointments cancelled/re-scheduled
Not being able to see doctor in person / Physical exam
Delays / Long waits (unspecified)
57%
33%
9%
6%
17%
OVERALL, 54% ARE VERY
SATISFIED WITH THE
QUALITY OF CARE RECEIVED
DURING COVID-19
WHILE 20% ARE SOMEWHAT
SATISFIED AND 11% ARE
SOMEWHAT UNSATISFIED
OR NOT AT ALL SATISFIED
50%
22%
7%
2%
20%
METASTATIC
STAGE – 67%
ABOUT HALF OF THOSE
SURVEYED HIGHLIGHT
ACCESS TO HEALTH CARE AS
THEIR MAIN CONCERN
ABOUT RECEIVING CARE
DURING THIS CRISIS
With increase in in-person consultations, JUST OVER HALF say they are VERY SATISFIED with the QUALITY
OF CANCER CARE received during the pandemic. CONCERNS around ACCESS TO HEALTHCARE and DELAYS
IN GETTING CARE DRIVE DISSATISFACTION with quality of cancer care.
19
19. 37% ARE CONCERNED ABOUT BEING ABLE TO RECEIVE HOSPITAL
CARE IF NEEDED
36% ARE CONCERNED ABOUT BEING ABLE TO BE CARED FOR IN ER IF
NEEDED
30% ARE CONCERNED ABOUT BEING ABLE TO RECEIVE CANCER
TREATMENT IN TIMELY FASHION
30% ARE CONCERNED ABOUT COVERAGE AND FUNDING OF NEW
TREATMENTS
32% ARE CONCERNED ABOUT RECEIVING IN-PERSON CARE
31% ARE CONCERNED BEING ABLE TO GET TESTS RELATED TO
CANCER
28% ARE CONCERNED ABOUT AVAILABILITY OF NEW TREATMENTS
23% ARE CONCERNED ABOUT BEING ABLE TO GET HELP FOR SIDE
EFFECTS RELATED TO TREATMENT OR NEW SYMPTOMS
28% ARE CONCERNED ABOUT BEING ABLE TO SEE DOCTOR
MANAGING CANCER FOR FOLLOW-UPS
PATIENTS CAREGIVERS PRE-DIAGNOSIS
36%
35%
32%
30%
30%
29%
29%
28%
23%
64%
64%
61%
59%
58%
60%
57%
60%
59%
56%
52%
57%
53%
54%
54%
47%
53%
N/A
*VERY + SOMEWHAT CONCERNED
NOTE: RECENTLY DIAGNOSED = DIAGNOSED <2 YEARS AGO, ADJUVANT STAGE = STAGE 1/2/3 CANCER & METASTATIC STAGE = STAGE 4 CANCER
MAIN CONCERNS* ONCE COVID-19 RESTRICTIONS ARE LIFTED
METASTATIC STAGE – 50%
ADJUVANT STAGE – 38%
RECENTLY DIAGNOSED – 44%
METASTATIC STAGE – 74%
METASTATIC STAGE – 78%
METASTATIC STAGE – 70%
59% say they are likely to remain concerned about RECEIVING ADEQUATE HEALTH CARE, even when
COVID-19 RESTRICTIONS ARE LIFTED after the second wave
20
20. COVID-19 CONTINUES TO AFFECT* MOST
ASPECTS OF EVERYONE’S LIFE, CAUSING
FEARS FOR THE FUTURE & INCREASED LEVEL
OF ANXIETY AND IMPACTING OVERALL STATE
OF HEALTH AND WELLBEING
PATIENTS CAREGIVERS PRE-DIAGNOSIS
NOTE: RECENTLY DIAGNOSED = DIAGNOSED <2 YEARS AGO
METASTATIC STAGE = STAGE 4 CANCER
*SIGNIFICANT + SOME AFFECT
53% (vs. 56% in W1) EXPRESS FEARS FOR THE FUTURE
53% (vs. 55% in W1) HAVE INCREASED LEVELS OF
ANXIETY
49% (vs. 43% in W1) FEAR THE CANCER WILL PROGRESS
45% (vs. 44% in W1) SAY IT HAS AFFECTED THEIR
OVERALL STATE OF HEALTH AND WELLBEING
45%
45%
40%
37%
79%
81%
77%
69%
70%
68%
64%
60%
AFFECT OF COVID-19 ON THE FOLLOWING ASPECTS OF LIFE
(73%)
(51%)
(68%)
(60%)
RECENTLY DIAGNOSED – 61%
METASTATIC STAGE – 64%
RECENTLY DIAGNOSED – 62%
METASTATIC STAGE – 62%
RECENTLY DIAGNOSED – 58%
METASTATIC STAGE – 67%
RECENTLY DIAGNOSED – 54%
METASTATIC STAGE – 54%
(#) represents W1 data
Those who are PRE-DIAGNOSED (70%) with cancer or RECENTLY DIAGNOSED (61%) and those in the
METASTATIC STAGE (64%) continue to WORRY ABOUT THE FUTURE. NEARLY HALF (49%), slightly up from
last wave, FEAR that their CANCER WILL PROGRESS.
21
21. CONCLUSIONS
Cancer patients, caregivers and those pre-diagnosed with cancer continue to face challenges with doctor appointments with
55% (vs. 54% in W1) reporting CANCER CARE APPOINTMENTS BEING CANCELLED, POSTPONED OR RESCHEDULED.
• THREE-QUARTERS of METASTATIC STAGE patients and SIX-IN-TEN PRE-DIAGNOSED with cancer and RECENTLY
DIAGNOSED patients report having appointments cancelled, postponed or rescheduled.
Among those who had in-person appointments and scheduled procedures/surgeries cancelled or postponed, it took on
average 34 DAYS to RESCHEDULE THE APPOINTMENT and on average 52 DAYS to RESCHEDULE THE PROCEDURE/SURGERY.
• Moreover, 36% say they don’t have a rescheduled appointment time yet and 46% say they don’t have a rescheduled
procedure/surgery time yet.
Delays in appointments and treatment continue to affect all, with 72% (vs. 74% in W1) reporting the delays having a MAJOR
IMPACT on their MENTAL and EMOTIONAL HEALTH.
• PATIENTS are SIGNIFICANTLY MORE CONCERNED this wave about RECEIVING CARE in HOSPITAL / ER if needed and
receiving CANCER TREATMENT in a timely manner.
Appointments being cancelled / postponed and concerns around receiving adequate cancer care have fueled anxieties with
LEVEL OF ANXIETY BACK to what it was DURING the HEIGHT of the FIRST WAVE of the pandemic.
1
2
3
4
22
22. CONCLUSIONS
Among those who interacted with physicians during the pandemic, there was a SIGNIFICANT INCREASE IN IN-PERSON
INTERACTIONS REPORTED. There were also a significant number of virtual – mostly telephone appointments.
• For all, access to healthcare, including HCPs, treatments, tests, etc., continues to be a leading concern about
receiving care during the pandemic.
The good news is that JUST OVER HALF (54%) WERE SATISFIED WITH THE QUALITY OF CANCER CARE they received during
the pandemic. However, many were not satisfied, mainly due to delays in getting care, doctors not being available/
cancelling appointments, unknown status of treatment/ appointments and having to deal with their doctor over the phone
vs. in-person.
Challenges still exist, as SIX-IN-TEN express concerns about RECEIVING ADEQUATE HEALTH CARE even when COVID-19
RESTRICTIONS ARE LIFTED. Fear of cancer progressing has gone up slightly this wave (49% vs. 43% in W1).
5
6
23
7
23. CANADIAN CANCER SURVIVOR NETWORK
CONTACT INFO
1750 Courtwood Crescent, Suite 210
Ottawa, ON K2C 2B5
Telephone / Téléphone : 613-898-1871
E-mail: jmanthorne@survivornet.ca or info@survivornet.ca
Website: www.survivornet.ca
Twitter: @survivornetca
Facebook: www.facebook.com/CanadianSurvivorNet
Instagram: @survivornet_ca
Pinterest: http://pinterest.com/survivornetwork/
24